RankingsPricing
  1. JP-listed companies
  2. Pharmarise Holdings Corporation
  3. Financials
  4. Dividend per share

Pharmarise Holdings CorporationJP:2796

Market cap
¥6.4B
P/E ratio
22.6x
SummaryFinancialsHistorySegmentsOwnershipWorkforce
Period EndDividend per share (JPY)YoY (%)
May 31, 202514-30.00%
May 31, 202420+42.86%
May 31, 202314+0.00%
May 31, 202214+0.00%
May 31, 202114+0.00%
May 31, 202014+0.00%
May 31, 201914+0.00%
May 31, 201814+0.00%
May 31, 201714+0.00%
May 31, 201614-12.50%
May 31, 201516+14.29%
May 31, 201414-99.00%
May 31, 20131,400+40.00%
May 31, 20121,000-61.54%
May 31, 20112,600

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)